Welcome to BioReagent Hub Hotline:19920083827
本站自营/精选产品 www.yeasen.com  |  价格与库存以本站实时信息为准
本站精选 · 品质自营查看原始页面 ›
Vendor Tel:400-6111-883
Product data sheet PD-96859ES
Recombinant Canine LIF R/CD118 Protein,His Tag Recombinant Canine LIF R/CD118 Protein,His Tag
Enquiry

Tell us your volume and application; we reply with a quote.

Start enquiry

Recombinant Canine LIF R/CD118 Protein,His Tag

Scan for product
HEK293表达系统ELISA靶点蛋白/抗体药物靶点研究
Product no.96859ES Sizes3 options SourceYeasen · Official
Cat. No. 96859ES25
现货 $1,415.00
Qty 1
Enquire now
Enquire / bulk Compare

Specifications & Enquiry

Tick the specs you need to submit them together; or enquire one by one. Cat. numbers are carried into the RFQ.

Cat.No Spec Price Status
96859ES25 25 μg $1,415.00 现货 Enquire
96859ES60 100 μg $5,175.00 现货 Enquire
96859ES76 500 μg $17,245.00 现货 Enquire
Submit enquiry Price is on application; bulk sizes can be sampled on request.

Overview

Specifications

Brand翌圣生物 Yeasen
Cat.No96859ES
Specification高活性、高纯度、低内毒素、高稳定性
Origin翌圣生物科技(上海)股份有限公司
技术平台 HEK293表达系统
应用方法 ELISA检测重组蛋白与配体的结合活性 靶点蛋白/抗体药物靶点研究作为LIF R/CD118重组靶点蛋白用于抗体药物筛选与验证
适用物种种属 犬
检测方法 酶联免疫吸附试验(ELISA) Bis-Tris聚丙烯酰胺凝胶电泳(Bis-Tris PAGE) 高效液相色谱(HPLC) 鲎试剂法(LAL法)
生物特性参数 蛋白类型重组蛋白/靶点蛋白 种属来源犬(Canine) 生物活性描述ELISA检测与人LIF结合的EC50为25.4 ng/ml;高活性 应用ELISA结合活性检测;靶点蛋白/抗体药物靶点研究 产品别称FLJ99923; SJS2; STWS; SWS; LIFR; CD118; FLJ98106 Accession号AAU43788.1 表达序列Recombinant Canine LIF R/CD118 Protein expressed from HEK293 with His tag at C-terminus;含有Glu45-Ser833
样本类型 重组蛋白
技术参数 纯度>95% (Bis-Tris PAGE);>95% (HPLC) 内毒素水平Less than 0.1 EU per μg by the LAL method 分子量预测MW 91.21 kDa;由于糖基化,经Bis-Tris PAGE迁移至120-150 kDa 制剂形式Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4);冻干前添加8%海藻糖作为保护剂 储存条件-25~-15℃保存,有效期1年;复溶后-85~-65℃保存,3个月有效期;避免反复冻融 外观冻干粉 表达系统HEK293 标签C-His 复溶方法用蒸馏水溶解冻干蛋白;25μg或100μg建议复溶至0.5mg/mL,500μg建议复溶至1mg/mL;避免剧烈涡旋或摇晃;分装后-80℃保存,避免反复冻融 活性高活性;ELISA测定EC50为25.4 ng/ml
实验类型 ELISA测定Canine LIF R与Human LIF结合的剂量反应曲线及EC50 Bis-Tris PAGE检测蛋白纯度及表观分子量 HPLC检测蛋白纯度 LAL法检测内毒素水平

Recommended reading

Related products

✉Email 💬Message 👤Member
↑Top